The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons

被引:15
作者
Mochizuki, M
Takada, Y
Urano, T
Nagai, N
Nakano, T
Nakajima, K
Takada, A
机构
[1] HAMAMATSU UNIV SCH MED, DEPT PHYSIOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
[2] HAMAMATSU UNIV SCH MED, DEPT PATHOPHYSIOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
[3] JAPAN IMMUNORES LABS, TAKASAKI, GUMMA 379, JAPAN
关键词
remnant lipoprotein; platelet aggregation; chylomicron; VLDL;
D O I
10.1016/0049-3848(96)00033-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the in vitro influence of chylomicron (CM) remnant and very low density lipoprotein (VLDL) remnant on platelet aggregation in healthy persons. The separation of CM and VLDL remnants from serum was performed using an immunoaffinity gel mixture containing anti apo B-100 and anti apo A-1 antibodies coupled to Sepharose 4B. The preincubation with CM and VLDL remnants significantly enhanced the platelet aggregation in whole blood and in platelet rich plasma (PRP) induced by collagen. This effect was observed in whole blood with the addition of VLDL remnant at the concentration of 5 mu g/ml, and in PRP with the addition of CM remnant at the concentration of 1 and 5 mu g/ml, and with the addition of VLDL remnant at the concentration of 5 and 10 mu g/ml. These results may indicate that increase in remnant lipoproteins may be a part of the reasons for atherosclerotic and thrombotic complications.
引用
收藏
页码:583 / 593
页数:11
相关论文
共 37 条
[1]   FACTORS INFLUENCING PLATELET-AGGREGATION IN WHOLE-BLOOD [J].
ABBATE, R ;
FAVILLA, S ;
BODDI, M ;
COSTANZO, G ;
PRISCO, D .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 86 (01) :91-96
[2]   INTRACELLULAR MECHANISMS IN THE ACTIVATION OF HUMAN-PLATELETS BY LOW-DENSITY LIPOPROTEINS [J].
ANDREWS, HE ;
AITKEN, JW ;
HASSALL, DG ;
SKINNER, VO ;
BRUCKDORFER, KR .
BIOCHEMICAL JOURNAL, 1987, 242 (02) :559-564
[3]   CHLOMICRONS FROM PATIENTS WITH TYPE-V HYPERLIPOPROTEINEMIA INHIBIT PLATELET FUNCTION [J].
AVIRAM, M ;
FURMAN, B ;
BROOK, JG .
ATHEROSCLEROSIS, 1985, 56 (02) :157-167
[4]   PLATELET ACTIVATION BY PLASMA-LIPOPROTEINS [J].
AVIRAM, M ;
BROOK, JG .
PROGRESS IN CARDIOVASCULAR DISEASES, 1987, 30 (01) :61-72
[5]   PLATELET INTERACTION WITH HIGH AND LOW-DENSITY LIPOPROTEINS [J].
AVIRAM, M ;
BROOK, JG .
ATHEROSCLEROSIS, 1983, 46 (03) :259-268
[6]   PLATELET CHANGES AFTER A SATURATED FAT MEAL AND THEIR PREVENTION BY DAZMEGREL, A THROMBOXANE SYNTHETASE INHIBITOR [J].
BELCH, JJF ;
SANIABADI, AR ;
MCLAUGHLIN, K ;
FORBES, CD .
LIPIDS, 1987, 22 (03) :159-162
[7]   PLATELET LIPOPROTEIN INTERACTIONS [J].
BROOK, JG ;
AVIRAM, M .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1988, 14 (03) :258-265
[8]  
CAMPOS E, 1992, J LIPID RES, V33, P369
[9]  
FOGER B, 1993, CURR OPIN LIPIDOL, V4, P428
[10]  
GINSBERG HN, 1994, MED CLIN N AM, V78, P1